Imunon (NASDAQ:IMNN) is set to give its latest quarterly earnings report on Thursday, 2025-11-13. Here's what investors need to know before the announcement.
Analysts estimate that Imunon will report an earnings per share (EPS) of $-1.79.
Imunon bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Historical Earnings Performance
In the previous earnings release, the company beat EPS by $1.96, leading to a 6.22% drop in the share price the following trading session.
Here's a look at Imunon's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | -3.83 | -4.70 | -4.7 | -5.22 |
| EPS Actual | -1.87 | -3.65 | -3.0 | -4.43 |
| Price Change % | -6.00 | -2.00 | 10.0 | -3.00 |
Tracking Imunon's Stock Performance
Shares of Imunon were trading at $3.85 as of November 11. Over the last 52-week period, shares are down 60.23%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
To track all earnings releases for Imunon visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
